Resveratrol-induced autophagy promotes survival and attenuates doxorubicin-induced cardiotoxicity

International Immunopharmacology

Volumn 32, Issue , 2016, Pages 1-7

  Gu, Jun ^a,b   Hu, Wei ^b   Song, Zhi Ping ^b   Chen, Yue Guang ^b   Zhang, Da Dong ^b   Wang, Chang Qian ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Autophagy; Cardiotoxicity; Chemotherapy; Doxorubicin; Resveratrol

Indexed keywords

CASPASE 3; DOXORUBICIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; PROTEIN ULK1; RESVERATROL; UNCLASSIFIED DRUG; ANTINEOPLASTIC ANTIBIOTIC; STILBENE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOPHAGY; CARDIOTOXICITY; CELL DAMAGE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DRUG MECHANISM; EMBRYO; ENZYME INHIBITION; HEART PROTECTION; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RAT MODEL; SIGNAL TRANSDUCTION; ANIMAL; CELL LINE; DRUG EFFECTS; METABOLISM; SPRAGUE DAWLEY RAT;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; AUTOPHAGY; CARDIOTOXICITY; CELL LINE; CELL SURVIVAL; DOXORUBICIN; RATS, SPRAGUE-DAWLEY; STILBENES;

EID: 84954109353     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2016.01.002     Document Type: Article

References (21)

1. P. Dent The flip side of doxorubicin: inflammatory and tumor promoting cytokines Cancer Biol. Ther. 14 2013 774 775
2. D.L. Hershman, R.B. McBride, A. Eisenberger, W.Y. Tsai, V.R. Grann, and J.S. Jacobson Doxorubicin, cardiac risk factors, and cardiac toxicity in elderly patients with diffuse B-cell non-Hodgkin's lymphoma J. Clin. Oncol. 26 2008 3159 3165
3. A. Longhi, S. Ferrari, G. Bacci, and S. Specchia Long-term follow-up of patients with doxorubicin-induced cardiac toxicity after chemotherapy for osteosarcoma Anti-Cancer Drugs 18 2007 737 744
4. E.C. van Dalen, v.d. BM, C. HN, and K. LC Anthracycline-induced cardiotoxicity: comparison of recommendations for monitoring cardiac function during therapy in paediatric oncology trials Eur. J. Cancer 42 2006 3199 3205
5. G. Kara, O. Tasoglu, O. Dizdar, K. Altundag, and L. Ozcakar Stroke due to doxorubicin-induced cardiac toxicity Med. Oncol. 26 2009 506 507
6. S.T. Lin, H.C. Chou, Y.W. Chen, and H.L. Chan Redox-proteomic analysis of doxorubicin-induced altered thiol activity in cardiomyocytes Mol. BioSyst. 9 2013 447 456
7. J.A. Tallaj, V. Franco, B.K. Rayburn, L. Pinderski, R.L. Benza, S. Pamboukian, and et al. Response of doxorubicin-induced cardiomyopathy to the current management strategy of heart failure J. Heart Lung Transplant. 24 2005 2196 2201
8. S. Zhang, X. Liu, T. Bawa-Khalfe, L.S. Lu, Y.L. Lyu, L.F. Liu, and et al. Identification of the molecular basis of doxorubicin-induced cardiotoxicity Nat. Med. 18 2012 1639 1642
9. M. Jang, L. Cai, G.O. Udeani, K.V. Slowing, C.F. Thomas, C.W. Beecher, and et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes Science 275 5297 1997 218 220
10. X. Xu, K. Chen, S. Kobayashi, D. Timm, and Q. Liang Resveratrol attenuates doxorubicin-induced cardiomyocyte death via inhibition of p70 S6 kinase 1-mediated autophagy J. Pharmacol. Exp. Ther. 341 1 2012 183 195
11. A. Kuma, M. Hatano, M. Matsui, A. Yamamoto, H. Nakaya, T. Yoshimori, and et al. The role of autophagy during the early neonatal starvation period Nature 432 7020 2004 1032 1036
12. Y. Matsui, H. Takagi, X. Qu, M. Abdellatif, H. Sakoda, T. Asano, and et al. Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy Circ. Res. 100 6 2007 914 922
13. B.B. Aggarwal, A. Bhardwaj, R.S. Aggarwal, N.P. Seeram, S. Shishodia, and Y. Takada Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies Anticancer Res. 24 5 A 2004 2783 2840
14. Y.A. Rezk, S.S. Balulad, R.S. Keller, and J.A. Bennett Use of resveratrol to improve the effectiveness of cisplatin and doxorubicin: study in human gynecologic cancer cell lines and in rodent heart Am. J. Obstet. Gynecol. 194 5 2006 e23 e26
15. J. Kim, M. Kundu, B. Viollet, and K.L. Guan AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1 Nat. Cell Biol. 13 2 2011 132 141
16. J. Zhang, J. Chiu, H. Zhang, T. Qi, Q. Tang, K. Ma, and et al. Autophagic cell death induced by resveratrol depends on the Ca(2 +)/AMPK/mTOR pathway in A549 cells Biochem. Pharmacol. 86 2 2013 317 328
17. M.M. Poulsen, J.O. Jorgensen, N. Jessen, B. Richelsen, and S.B. Pedersen Resveratrol in metabolic health: an overview of the current evidence and perspectives Ann. N. Y. Acad. Sci. 1290 2013 74 82
18. J. Marchal, F. Pifferi, and F. Aujard Resveratrol in mammals: effects on aging biomarkers, age-related diseases, and life span Ann. N. Y. Acad. Sci. 1290 2013 67 73
19. K.T. Howitz, K.J. Bitterman, H.Y. Cohen, D.W. Lamming, S. Lavu, J.G. Wood, and et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan Nature 425 2003 191 196
20. J.J. Smith, R.D. Kenney, D.J. Gagne, B.P. Frushour, W. Ladd, H.L. Galonek, and et al. Small molecule activators of SIRT1 replicate signalling pathways triggered by calorie restriction in vivo BMC Syst. Biol. 3 2009 31
21. J.A. Baur, K.J. Pearson, N.L. Price, H.A. Jamieson, C. Lerin, A. Kalra, and et al. Resveratrol improves health and survival of mice on a high calorie diet Nature 444 2006 337 342